Pneumoconiosis Symptoms


Pneumoconiosis Symptoms

In the early stages of pneumoconiosis, symptoms are usually mild and intermittent. Some people do not experience any warning signs until they have sustained several years of damage to their lungs. As pneumoconiosis progresses, however, its symptoms tend to become more frequent and severe. These more advanced symptoms can make it difficult to work, exercise or participate in normal daily activities.

The most common symptoms of pneumoconiosis are coughing, wheezing and shortness of breath. These can be present when exercising or even when at rest. Other symptoms include:

  • A chronic feeling of tightness in the chest
  • An increased production of mucus
  • The development of a blue tint in the lips or fingernails (cyanosis)

People who have pneumoconiosis might also develop other related conditions as a result of existing lung damage or inflammation, such as bronchitis, pulmonary hypertension or emphysema. These conditions can cause additional complications that accompany those of pneumoconiosis.

Because pneumoconiosis symptoms can be so disruptive to day-to-day life, finding an effective treatment plan is incredibly important. Many people rely on treatments such as medications, supplemental oxygen and pulmonary rehabilitation to help alleviate their symptoms. Some individuals also consider alternative treatments, such as stem cell therapy, to further improve their quality of life.

At the Lung Institute, we provide stem cell therapy to help promote the body’s natural healing processes. Our treatments use a patient’s own stem cells and are performed on an outpatient basis. More than 80 percent of our patients report an improvement in their quality of life after treatment.

If you have been dealing with the symptoms of pneumoconiosis and would like to learn more about stem cell therapy as an alternative treatment option, you can contact the Lung Institute at (800) 729-3065. Whenever it’s most convenient for you, we’re here to help you breathe easier.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.